iollo
Building Quinn, an AI scientist accelerating pharma/biotech R&D
About the Company
iollo has developed Quinn, our AI scientist to analyze multimodal biomedical data to discover new biology in hours, work that typically takes teams of scientists years. Quinn translates these discoveries into accelerated development of novel therapeutic strategies and interventions for extending healthspan.
Tech Stack
Our tech stack includes: Infrastructure: AWS (Lambda, ECS, Fargate, S3, App Runner, Cognito, Aurora PostgreSQL, SQS), deployed via AWS CDK/Terraform Backend: Node.js, Nest.js, R, Python (for AI/ML services) Frontend: React, TypeScript, Tailwind, deployed on Vercel Databases: PostgreSQL, MongoDB, Redis Architecture: Event-driven microservices, serverless functions
Founders
Daniel Gomari is the founder and CEO of iollo. He was previously a postdoctoral researcher at Stanford University where he led projects on healthy aging and lifespan extension. He received his PhD in Computational Biology, where he built and applied machine learning methods for drug repurposing, with applications in cancer and diabetes patient metabolomics data.
Open Positions at iollo (2 Jobs)
Ready to start your space career at iollo?
